ST PAUL - 3M has announced additional details about its capacity increases of N95 respirators, strong measures to combat price gouging and counterfeiting, and new partnerships to help protect healthcare workers.
“As previously communicated, beginning in January we ramped up to maximum production of N95 respirators, doubling our global output to a rate of 1.1 billion per year, or 100 million per month,” said 3M chairman and CEO Mike Roman. “This includes 35 million per month in the United States, and over just the last seven days we have delivered 10 million N95 respirators to healthcare facilities in states across the country.